Antimalarial Potency of Vernonia Amygdalina Ethanolic Extracts in the Prevention and Treatment of Plasmodium Berghei-Infected Mice
Abstract
Objective: This study assessed the anti-malarial potency of Vernonia amygdalina ethanolic extracts (leaf and stem-bark) in the prevention and treatment of Plasmodium berghei-infected mice.
Material and Methods: Fresh leaves and stem bark of Vernonia amygdalina were collected in Kurmi LGA, Taraba State, based on ethnobotanical guidance, and authenticated at Ahmadu Bello University, Zaria (voucher number 02006). Non-pregnant mice (20–35 g) were acclimatized at the Modibbo Adama University Infectious Diseases Research Laboratory, Yola, for 14 days before curative (70 mice) and prophylactic (40 mice) tests. Plant extracts were administered orally, and parameters such as parasitemia, body weight, temperature, packed cell volume (PCV), and mean survival time (MST) were monitored.
Results: The leaf extract at 600 mg/kg demonstrated the highest parasitemia suppression (60.78%) with a significant increase in the MST of the infected mice. Similarly, the stem-bark extract at the same dose exhibited 60.62% parasitemia suppression, with the MST also significantly extended. In both cases, suppression rates and MST were dose-dependent, with higher doses providing better outcomes. The prophylactic test revealed that a dose of 200 mg/kg of leaf extract achieved 91.67% suppression of parasitemia, outperforming the stem-bark extract. The MST was significantly increased in all treated groups compared to the untreated controls.
Conclusion: The study demonstrates that Vernonia amygdalina ethanolic extracts, particularly from the leaf, possess significant anti-malarial activity, supporting its potential use in malaria treatment. In addressing artemisinin resistance, Vernonia amygdalina extracts may exert their antiplasmodial effects through molecular mechanisms distinct from those targeted by artemisinin.
Keywords
Full Text:
PDFReferences
WHO. World Malaria Report. [homepage on the Internet]. Geneva: World Health Organization; 2022 [cited 2025 Jan 22]. Available from: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022
Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, Palmer A, et al. The prevalence of malaria in children in Africa, 2000–2015. Nature 2017;526:207–11.
Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 2015;526:207–11.
Siciliano G, Alano P. Enabling technologies for malaria research. Trends Parasitol 2015;31:457–66.
Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg 2001;64(1_suppl):85–96.
United States Agency for International Development (USAID). President’s Malaria Initiative: Strategy and Impact Report [monograph on the Internet]. Washington (DC): USAID; 2023 [cited 2025 Jan 21]. Available from: https://www.malarianomore.org/wp-content/uploads/imported-files/10.04Final_USAID_PMI_Report_50851.pdf
Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2014;371:411–23.
Menard D, Dondorp AM. Antimalarial drug resistance: a threat to malaria elimination. Lancet Infect Dis 2017;17:e1–10.
Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 2020;83:770–803.
Willcox M, Bodeker G. Traditional herbal medicines for malaria. BMJ 2004;329:1156–9.
Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 2013;1830:3670–95.
Peters W. Chemotherapy and drug resistance in malaria [homepage on the Internet]. London: Academic Press; 1987 [cited 2025 Jan 22]. Available from: https://kohahq.searo.who.int/cgi-bin/koha/opac-detail.pl?biblionumber=1777
Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov 2004;3:509–20.
Ajayi IO, Adebayo E, Onikepe FO. Medicinal plants with antimalarial potential: a review. J Med Plants Res 2020;14:329–46.
Center for Drug Evaluation and Research (CDER). CDER guideline for testing of chemicals. Acute oral toxicity “Up-and-Down Procedure.” Washington (DC): CDER; 2011;p.12–6.
Gavamukulya Y, Abou-Elella F, Wamunyokoli F, El-Shemy HA. Phytochemical screening, antioxidant activity, and in vitro anticancer potential of ethanolic and water leaves extracts of Annona muricata (Graviola). Asian Pac J Trop Med 2014;7:355–63.
Bero J, Frederich M, Quetin-Leclercq J. Antimalarial compounds isolated from plants used in traditional medicine. J Pharm Pharmacol 2013;65:1667–79.
Boampong JN, Ameyaw EO, Aikins M, Badu M, Owusu-Ofori A. The antimalarial potential of Vernonia amygdalina. J Ethnopharmacol 2015;162:233–9.
Mueller MS, Karhagomba IB, Hirt HM, Wemakor E. The potential of Artemisia annua L. as a locally produced remedy for malaria in the tropics: agricultural, chemical, and clinical aspects. J Ethnopharmacol 2004;95:339–49.
Eloff JN. Which extractant should be used for the screening and isolation of antimicrobial components from plants? J Ethnopharmacol 1998;60:1–8.
Oyewole IO, Ibidapo CA, Moradeyo OK, Oduola AO. Prophylactic activity of vernonia amygdalina aqueous leaf extract in mice infected with plasmodium berghei. Parasitol Res 2010;107:641–4.
Omoregie ES, Pal A. Prophylactic efficacy of Vernonia amygdalina extract against malaria infection in rodent models. Malar Res Treat 2016;2016:1–6.
Adebayo JO, Krettli AU. Potential antimalarials from Nigerian plants: a review. J Ethnopharmacol 2011;2:289–302.
Babylon P, Napthtali RS, Emmanuel WB, Atinga A. Evaluation of the antimalarial activity of Garcinia kola ethanolic extracts in the prevention and treatment of Plasmodium berghei-infected mice. J Adv Med Pharm Sci 2024;26:154–62.
Newman DJ, Cragg GM. Natural products as sources of new drugs. J Nat Prod 2020;83:770–803.
Iwalokun BA. Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine-resistant Plasmodium berghei strains. Afr Health Sci 2008;8:25–35.
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014;505:50–5.
Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, et al. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science 2015;347:431–5.
Bhattacharya D, Dey A, Debnath S. Antimalarial activity of some flavonoids: structure–activity relationship studies. Phytother Res 2009;23:1566–70.
Tiwari V, Darmani NA, Singh S. Flavonoids as anticancer agents: mechanisms and clinical efficacy. Sci World J 2015;2015:302404.
Cimanga RK, Tona GL, Mesia KG, Kambu KO, Apers S, De Bruyne T, et al. In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. J Ethnopharmacol 2004;93:27–32.
Bero J, Frederich M, Quetin-Leclercq J. Antimalarial compounds isolated from plants used in traditional medicine. J Pharm Pharmacol 2009;61:1401–33.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.